>
   
Disease Markers

IMPACT FACTOR: 2,026 (JCR '09)

ISSN: 0278-0240
Volume 28-29; 12 issues
Institutional subscription (print and online) for 2010: €1514 / US$2315 (including postage and handling)
Click on the subscribe button for more options, including personal subscription prices.
Status Report: Last issue (volume 28:4) online on 09 June 2010
Next issue (volume 28:5) scheduled for July 2010

Aims and Scope
Editorial Board
Submission of Manuscripts
Abstracted in
Download flyer for this journal
Editor
Sudhir Srivastava Ph.D. MPH
C/o IOS Press Inc.
4502 Rachael Manor Drive
Fairfax, VA 22032
USA
Tel.: +1 703 239 2260
Fax:+1 703 323 3668
E-mail: submissions@iospress.com

Associate Editor
Michele Carbone MD, PhD
E-mail: mcarbone@crch.hawaii.edu

 
Editorial Board
D. Alberts, Tuscon, AZ, USA L.A. Liotta, Manassas, VA, USA
P.G. Anker, Geveva, Switzerland D. Lo, Hong Kong, China
S.G. Baker, Bethesda, MD, USA P. Lynch, Houston, TX, USA
B. Bapat, Toronto, Ontario, Canada H. Magdelenat, Paris, France
P.E. Barker, Gaithersburg, MD, USA H. Malm, Chicago, IL, USA
M. J. Birrer, Rockville, MD, USA U. Manne, Birmingham, AL, USA
T.M. Block, Doylestown, PA, USA L. Mao, Houston, TX, USA
P. Bofetta, Lyon, France J. Marrero, Ann Arbor, MI, USA
W. Busse, Madison, WI, USA F. Olopade, Chicago, IL, USA
K. Chaudry, New Delhi, India G. Perry, San Antonio, TX, USA
R.G.H. Cotton, Fitzroy, Australia G. Rennert, Haifa, Israel
G.J. Downing, Bethesda, MD, USA R. Schleimer, Baltimore, MD, USA
Z. Feng, Seattle, WA, USA J.W. Shay, Dallas, TX, USA
J. Greenman, Hull, United Kingdom I. Shoulson, Rochester, NY, USA
S.M. Hanash, Ann Arbor, MI, USA M.A. Smith, Cleveland, OH, USA
G. Haroske, Dresden, Germany M. Steel, St. Andrews, United Kingdom
M. Harrington, Pasadena, CA, USA R.L. Strausberg, Rockville, MD, USA
N.K. Hayward, Herston, Australia E. Tahara, Hiroshima, Japan
W.N. Hittelman, Houston, TX, USA H. Vainio, Lyon, France
S. Kaneko, Kanazawa, Japan M. Von Knebel Doeberitz, Heidelberg, Germany
B. Levin, Houston, TX, USA 

Submission of Manuscripts 
See instructions to authors.
Aims and Scope 
The journal publishes original research findings (and reviews solicited by the Editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may be a genetic host factor predisposing to the disease or the occurrence of cell-surface markers, enzymes or other components, either in altered forms, abnormal concentrations or with abnormal tissue distribution. This journal is designed to provide a forum for publications dealing with original observations in this developing field on any aspect of the general topic including:

  • Identification of new genetic or non-genetic markers (e.g., cell-surface antigens, serum proteins, intra- and extra-cellular enzymes, cytogenic markers and DNA-sequences)
  • Population studies of new and existing markers, designed to elucidate information on their normal distribution as well as that in disease states
  • Amplification of knowledge about existing markers
  • Family studies of markers in disease
  • New techniques for identification and/or isolation of important marker molecules
  • Use of monoclonal antibodies for the definition of molecular structures associated with disease markers
  • Identification of disease-associated abnormalities in DNA using recombinant DNA techniques, gene-cloning and DNA restriction enzyme fragment polymorphisms
  • Identification of markers identifying malignantly transformed neoplastic cells.

 
Abstracted in
Biotechnology Citation Index, CAB Health, EBSCO database, Index Copernicus, Journal Citation Reports/Science Edition, Pubmed, PubsHub, Reference Update, Science Citation Index-Expanded (SciSearch®), Scopus
Backvolumes
1-27
Conferences

IOS Press
Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands
Tel.: +31 20 688 3355, Fax: +31 20 687 0019
E-mail: info@iospress.nl